ATE109357T1 - Transdermales estradiol als therapeutisches sytem. - Google Patents

Transdermales estradiol als therapeutisches sytem.

Info

Publication number
ATE109357T1
ATE109357T1 AT89903563T AT89903563T ATE109357T1 AT E109357 T1 ATE109357 T1 AT E109357T1 AT 89903563 T AT89903563 T AT 89903563T AT 89903563 T AT89903563 T AT 89903563T AT E109357 T1 ATE109357 T1 AT E109357T1
Authority
AT
Austria
Prior art keywords
pressure
estradiol
sheet material
sensitive adhesive
therapeutic system
Prior art date
Application number
AT89903563T
Other languages
English (en)
Inventor
Gregory R Nelson
Horst-Georg Zerbe
Cheryl L Moore
Steven M Wick
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of ATE109357T1 publication Critical patent/ATE109357T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT89903563T 1988-02-26 1989-02-27 Transdermales estradiol als therapeutisches sytem. ATE109357T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16063588A 1988-02-26 1988-02-26
CA000594966A CA1338819C (en) 1988-02-26 1989-03-29 Transdermal estradiol delivery system

Publications (1)

Publication Number Publication Date
ATE109357T1 true ATE109357T1 (de) 1994-08-15

Family

ID=25672560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903563T ATE109357T1 (de) 1988-02-26 1989-02-27 Transdermales estradiol als therapeutisches sytem.

Country Status (9)

Country Link
EP (1) EP0402407B1 (de)
JP (1) JP2931002B2 (de)
AT (1) ATE109357T1 (de)
AU (2) AU630347B2 (de)
CA (1) CA1338819C (de)
DE (1) DE68917292T2 (de)
LU (1) LU88849I2 (de)
NL (1) NL970007I1 (de)
WO (1) WO1989007951A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0364211B1 (de) * 1988-10-11 1994-12-21 Shire Holdings Ltd. Arzneimittelpräparat für perkutane Absorption
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
DE69007886T2 (de) * 1989-07-21 1994-11-17 Izhak Blank Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
CA2065311C (en) * 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
TW218849B (de) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5276079A (en) * 1991-11-15 1994-01-04 Minnesota Mining And Manufacturing Company Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
FR2691361B1 (fr) * 1992-05-19 1994-07-08 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
JP2819236B2 (ja) * 1994-05-06 1998-10-30 日東電工株式会社 経皮吸収製剤
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
JP3576608B2 (ja) * 1994-11-15 2004-10-13 日東電工株式会社 貼付剤および貼付製剤
CN1067875C (zh) * 1995-04-10 2001-07-04 浙江省医学科学院 雌二醇周效透皮吸收贴片
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
DE19546024C2 (de) 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
US5846558A (en) * 1996-03-19 1998-12-08 Minnesota Mining And Manufacturing Company Ionically conductive adhesives prepared from zwitterionic materials and medical devices using such adhesives
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US6232366B1 (en) 1999-06-09 2001-05-15 3M Innovative Properties Company Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
US6709716B2 (en) 2001-04-27 2004-03-23 3M Innovative Properties Company Microemulsion compositions and methods of making and using same
US9278155B2 (en) 2003-06-05 2016-03-08 3M Innovative Properties Company Adhesive compositions, articles incorporating same and methods of manufacture
US7999023B2 (en) 2004-12-03 2011-08-16 3M Innovative Properties Company Process for making pressure sensitive adhesive hydrogels
WO2020201878A1 (en) 2019-04-01 2020-10-08 3M Innovative Properties Company Process for making pressure sensitive adhesive hydrogels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate

Also Published As

Publication number Publication date
JPH03502925A (ja) 1991-07-04
CA1338819C (en) 1996-12-31
AU2097892A (en) 1992-10-22
LU88849I2 (fr) 2003-06-27
NL970007I1 (nl) 1997-04-01
AU630347B2 (en) 1992-10-29
EP0402407B1 (de) 1994-08-03
WO1989007951A1 (en) 1989-09-08
AU651234B2 (en) 1994-07-14
DE68917292T2 (de) 1995-02-02
JP2931002B2 (ja) 1999-08-09
DE68917292D1 (en) 1994-09-08
EP0402407A1 (de) 1990-12-19
AU3280989A (en) 1989-09-22

Similar Documents

Publication Publication Date Title
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
SE8605383D0 (sv) Flerfaldigt indelade transdermala och dermala plaster
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DE3685545D1 (de) System zur transdermalen abgabe von nitroglycerin.
DE59803647D1 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
NO895172L (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
IE800059L (en) Polymeric diffusion matrix
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
YU47290B (sh) Naprava za kontinualno ispuštanje nitroglicerina na kožu i postupak za izradu iste
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
ATE12731T1 (de) Polymere diffusionsmatrix und verfahren zu deren herstellung.
DE59001522D1 (de) Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen.
NO900270D0 (no) Fremgangsmaate for fremstilling av et overflateterapeutisksystem.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
AU6229086A (en) Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
DK72787D0 (da) Dermale og transdermale plastre med klaebemiddella g med diskontinuerligt moenster
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time